Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Niiya

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 1991
[Production and secretion of the plasminogen activator inhibitor type-2 in a leukemia cell line]K Niiya
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 1997
[The application of molecular biology to thrombosis and hemostasis]K Niiya, T Ozawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1992
[Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8]K Niiya, N Sakuragawa
Thrombosis Research|June 15, 1985
Oral administration of factor VIII concentrate preparation in von Willebrand's diseaseN Sakuragawa, K Niiya, S Kondo
Japanese Journal of Cancer Research : Gann|January 1, 1985
Establishment of a new human lymphoma line that secretes plasminogen activatorI Kubonishi, K Niiya, I Miyoshi
American Journal of Hematology|January 1, 1990
Thrombocytopenic purpura in a patient with lupus anticoagulant: requirement of both immunosuppressive and antithrombotic therapiesY Iwahara, K Niiya, K Yamato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1991
[Characterization of the factor VIII inhibitor in a patient with chronic renal failure]Y Uemura, K Niiya, T Takeuchi, et al.
Thrombosis Research|March 10, 2000
Induction of urokinase-type plasminogen activator by lipopolysaccharide in PC-3 human prostatic cancer cellsS Ohta, K Niiya, N Sakuragawa, et al.
American Journal of Hematology|August 1, 1996
Isolated recombinant domain of von Willebrand factor displaying increased sensitivity to ristocetinT Hayashi, J Ware, K Niiya, et al.
Biochimica Et Biophysica Acta|April 7, 1992
Synergistic stimulating effect between cyclic AMP and phorbol ester on plasminogen activator inhibitor type 2 production in human promyelocytic leukemia cell line PL-21T Hayashi, K Niiya, S Hirokawa, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 1991
[Production and secretion of the plasminogen activator inhibitor type-2 in a leukemia cell line]K Niiya
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 1997
[The application of molecular biology to thrombosis and hemostasis]K Niiya, T Ozawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1992
[Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8]K Niiya, N Sakuragawa
Thrombosis Research|June 15, 1985
Oral administration of factor VIII concentrate preparation in von Willebrand's diseaseN Sakuragawa, K Niiya, S Kondo
Japanese Journal of Cancer Research : Gann|January 1, 1985
Establishment of a new human lymphoma line that secretes plasminogen activatorI Kubonishi, K Niiya, I Miyoshi
American Journal of Hematology|January 1, 1990
Thrombocytopenic purpura in a patient with lupus anticoagulant: requirement of both immunosuppressive and antithrombotic therapiesY Iwahara, K Niiya, K Yamato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1991
[Characterization of the factor VIII inhibitor in a patient with chronic renal failure]Y Uemura, K Niiya, T Takeuchi, et al.
Thrombosis Research|March 10, 2000
Induction of urokinase-type plasminogen activator by lipopolysaccharide in PC-3 human prostatic cancer cellsS Ohta, K Niiya, N Sakuragawa, et al.
American Journal of Hematology|August 1, 1996
Isolated recombinant domain of von Willebrand factor displaying increased sensitivity to ristocetinT Hayashi, J Ware, K Niiya, et al.
Biochimica Et Biophysica Acta|April 7, 1992
Synergistic stimulating effect between cyclic AMP and phorbol ester on plasminogen activator inhibitor type 2 production in human promyelocytic leukemia cell line PL-21T Hayashi, K Niiya, S Hirokawa, et al.
Pageof 9